Evotec AG (NASDAQ:EVTCY) | WebDisclosure

Basculer en Français

8305	Companies
115226	Keywords
55530	Articles
62575	Press releases

Home
Companies
Evotec AG

BRIEF

published on 05/28/2024 at 07:35, 5 months 25 days ago

Evotec and CHDI Foundation Extend Collaboration on Huntington’s Disease Research

Drug Discovery Collaboration Evotec CHDI Foundation Huntington’s Disease
BRIEF

published on 05/28/2024 at 07:35, 5 months 25 days ago

Evotec et la Fondation CHDI étendent leur collaboration sur la recherche sur la maladie de Huntington

Collaboration Evotec Découverte De Médicament Fondation CHDI La Maladie De Huntington
PRESS RELEASE

published on 05/28/2024 at 07:30, 5 months 25 days ago

Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
Evotec SE extends strategic drug discovery collaboration with CHDI Foundation in Huntington's disease, emphasizing commitment to developing new therapies and improving patients' lives

Drug Discovery Evotec SE Therapeutics CHDI Foundation Huntington's Disease
BRIEF

published on 05/22/2024 at 07:05, 6 months ago

Evotec Reports Challenging Q1 2024 Results and Strategic Updates

Financial Results Q1 2024 Evotec Strategic Updates Biologics Growth
BRIEF

published on 05/22/2024 at 07:05, 6 months ago

Evotec annonce des résultats difficiles pour le premier trimestre 2024 et des mises à jour stratégiques

Résultats Financiers Evotec T1 2024 Mises À Jour Stratégiques Croissance Des Produits Biologiques
PRESS RELEASE

published on 05/22/2024 at 07:00, 6 months ago

Evotec reports Q1 2024 results and provides corporate update
Evotec SE reports Q1 2024 financial results and corporate update, outlines growth in Just - Evotec Biologics and challenges in transactional business. New CEO and CPO appointments. Group revenues expected to grow double-digit in FY 2024

Financial Results Evotec SE CEO Appointment Q1 2024 Just - Evotec Biologics
BRIEF

published on 05/15/2024 at 12:05, 6 months 7 days ago

Evotec SE to Announce Q1 2024 Financial Results on May 22

Financial Results Conference Call Biotechnology Evotec SE Q1 2024
BRIEF

published on 05/15/2024 at 12:05, 6 months 7 days ago

Evotec SE annoncera ses résultats financiers du premier trimestre 2024 le 22 mai

Résultats Financiers Biotechnologie Evotec SE Conférence Téléphonique T1 2024
PRESS RELEASE

published on 05/15/2024 at 12:00, 6 months 7 days ago

Evotec SE to announce results for first quarter 2024 on 22 may 2024
Evotec SE to announce financial results for the first quarter of 2024 on May 22, 2024, holding a conference call in English to discuss performance updates

Financial Results Conference Call Evotec SE First Quarter 2024 Performance Update
BRIEF

published on 04/30/2024 at 08:35, 6 months 22 days ago

Bayer and Evotec Focus on Advancing Precision Cardiology

Innovation Partnership Cardiovascular Diseases Precision Cardiology IPSCs

Accesswire

Published on 11/22/2024 at 09:00, 3 hours 19 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 12 hours 19 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 14 hours 14 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 14 hours 29 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 16 hours 4 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 11:54, 25 minutes ago

PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 34 minutes ago

How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 58 minutes ago

Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 1 hour 13 minutes ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/22/2024 at 11:00, 1 hour 19 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 1 day 5 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 5 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 5 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 16 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 16 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE